NNNN
Anbio Biotechnology Class A Ordinary Shares
NASDAQ: NNNN · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$27.43
-1.37% today
Updated 2026-04-29
Market cap
$1.20B
P/E ratio
182.87
P/S ratio
139.23x
EPS (TTM)
$0.15
Dividend yield
—
52W range
$6 – $56
Volume
0.0M
Anbio Biotechnology Class A Ordinary Shares (NNNN) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | $4.92M | $13.96M | $15.81M | $18.92M |
| Cash & equivalents | — | — | — | — |
| Current assets | $4.92M | $13.94M | $15.75M | $18.53M |
| Total liabilities | $2.38M | $1.41M | $993060.00 | $1.73M |
| Current liabilities | $2.38M | $1.41M | $993060.00 | $1.73M |
| Long-term debt | — | — | — | — |
| Shareholder equity | — | — | — | — |
| Retained earnings | $2.54M | $12.55M | $14.80M | $17.17M |
| Accounts receivable | $717500.00 | $3581.00 | $1.88M | $1.06M |
| Inventory | $0.00 | $353872.00 | $0.00 | — |
| Goodwill | — | — | — | — |